INTELLIGENT BIO SOLUTIONS INC. — Director's Dealing 2021

Feb 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GBS Inc. (GBS)
CIK: 0001725430
Period of Report: 2021-01-04

Reporting Person: Sakiris Spiro Kevin (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-04	Common Stock	X	1479	—	Acquired	6258	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-04	Series B Warrants	$	X	1479	Disposed		Common Stock (1479)	Direct

Footnotes

F1: Represents exercise of the Series B Common Stock Purchase Warrant (the "Warrant") to purchase 1,479 shares of the Company's common stock. The Reporting Person paid the exercise price of $17.00 per share on a cashless basis. The Warrant was exercisable until the fifth anniversary of the issuance date.